JUN and neoplasm: Mackall et al. first found that overexpression of C-JUN enhanced anti-tumor responses by downregulating inhibitory receptors PD-1 and CTLA-4, and upregulating pro-survival/memory factors IL-7R and TCF7 to resist exhaustion49.